These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26245815)

  • 1. Entrepreneurship.
    Yetisen AK; Volpatti LR; Coskun AF; Cho S; Kamrani E; Butt H; Khademhosseini A; Yun SH
    Lab Chip; 2015; 15(18):3638-60. PubMed ID: 26245815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercialization of nanotechnology.
    Hobson DW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):189-202. PubMed ID: 20049790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey reveals US university licensing up, startup formation down.
    Bouchie A
    Nat Biotechnol; 2005 Feb; 23(2):261-2. PubMed ID: 15724274
    [No Abstract]   [Full Text] [Related]  

  • 4. Applying the marketing mix (5 ps) to bionanotechnology.
    Tomczyk MS
    Methods Mol Biol; 2011; 726():393-411. PubMed ID: 21424463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Start-ups: A sense of enterprise.
    Savage N
    Nature; 2016 May; 533(7601):S10-2. PubMed ID: 27144602
    [No Abstract]   [Full Text] [Related]  

  • 6. Strategic rethink for German biotechnology.
    Fernandes M; Miska D
    Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106
    [No Abstract]   [Full Text] [Related]  

  • 7. Value drivers in licensing deals.
    Arnold K; Coia A; Saywell S; Smith T; Minick S; Löffler A
    Nat Biotechnol; 2002 Nov; 20(11):1085-9. PubMed ID: 12410249
    [No Abstract]   [Full Text] [Related]  

  • 8. Private company profiles.
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE23-8. PubMed ID: 12874973
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
    Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
    Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 12. Cash-strapped biotechs find financing alternative.
    Mitchell P
    Nat Biotechnol; 2004 Sep; 22(9):1057-8. PubMed ID: 15340452
    [No Abstract]   [Full Text] [Related]  

  • 13. The economics of licensing contracts.
    Mason R; Savva N; Scholtes S
    Nat Biotechnol; 2008 Aug; 26(8):855-7. PubMed ID: 18700253
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechnology in South Africa.
    Cloete TE; Nel LH; Theron J
    Trends Biotechnol; 2006 Dec; 24(12):557-62. PubMed ID: 17070947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sunbaked biotechnology in Australia.
    Littlejohn T
    Nat Biotechnol; 2002 Sep; 20(9):873-7. PubMed ID: 12205502
    [No Abstract]   [Full Text] [Related]  

  • 16. Tech transfer fails to translate into startups.
    Lawrence S
    Nat Biotechnol; 2007 Jun; 25(6):616. PubMed ID: 17557089
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology SMEs, start-ups, spin-offs or microenterprises are they molecules coming from the research results? If so, what place do they hold in the global industrial tissue?
    Doddoli R
    Biomol Eng; 2007 Feb; 24(1):3-4. PubMed ID: 16887388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotechnology and new companies arising from academia.
    Vallance P
    Lancet; 2001 Nov; 358(9295):1804-6. PubMed ID: 11734259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tales of two medical startup companies.
    Bottles K
    Physician Exec; 2001; 27(5):80-2. PubMed ID: 12881911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.